Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger, et al.
New England Journal of Medicine (2012) Vol. 367, Iss. 9, pp. 795-804
Open Access | Times Cited: 3373

Showing 1-25 of 3373 citing articles:

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack, David A. Bennett, Kaj Blennow, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 4, pp. 535-562
Open Access | Times Cited: 7701
Dementia prevention, intervention, and care
Gill Livingston, Andrew Sommerlad, Vasiliki Orgeta, et al.
The Lancet (2017) Vol. 390, Iss. 10113, pp. 2673-2734
Open Access | Times Cited: 5468
The amyloid hypothesis of Alzheimer's disease at 25 years
Dennis J. Selkoe, John Hardy
EMBO Molecular Medicine (2016) Vol. 8, Iss. 6, pp. 595-608
Open Access | Times Cited: 5110
2016 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2016) Vol. 12, Iss. 4, pp. 459-509
Closed Access | Times Cited: 4976
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack, David S. Knopman, William J. Jagust, et al.
The Lancet Neurology (2013) Vol. 12, Iss. 2, pp. 207-216
Open Access | Times Cited: 3938
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois, Howard Feldman, Claudia Jacova, et al.
The Lancet Neurology (2014) Vol. 13, Iss. 6, pp. 614-629
Open Access | Times Cited: 2992
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long, David M. Holtzman
Cell (2019) Vol. 179, Iss. 2, pp. 312-339
Open Access | Times Cited: 2339
2019 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2019) Vol. 15, Iss. 3, pp. 321-387
Closed Access | Times Cited: 2165
2020 Alzheimer's disease facts and figures
In this phase, individuals have measurable brain changes that indicate the earliest signs of Alzheimer's disease, but they have not yet developed symptoms such as memory loss. Examples of measurable brain changes …, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 391-460
Open Access | Times Cited: 2138
Alzheimer's disease
Chris Lane, John Hardy, Jonathan M. Schott
European Journal of Neurology (2017) Vol. 25, Iss. 1, pp. 59-70
Open Access | Times Cited: 2007
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
The Lancet Neurology (2013) Vol. 12, Iss. 4, pp. 357-367
Closed Access | Times Cited: 1987
2023 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 1986
2022 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2022) Vol. 18, Iss. 4, pp. 700-789
Closed Access | Times Cited: 1961
2021 Alzheimer's disease facts and figures
In the past, was often used to describe the dementia phase of the disease. Today we know that dementia is only …, Adult Disease, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 3, pp. 327-406
Closed Access | Times Cited: 1910
2018 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2018) Vol. 14, Iss. 3, pp. 367-429
Closed Access | Times Cited: 1796
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway, Reisa A. Sperling, Nick C. Fox, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 4, pp. 322-333
Open Access | Times Cited: 1791
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson, Ronald Lautner, Ulf Andréasson, et al.
The Lancet Neurology (2016) Vol. 15, Iss. 7, pp. 673-684
Open Access | Times Cited: 1767
2013 Alzheimer's disease facts and figures
William Thies, Laura Bleiler
Alzheimer s & Dementia (2013) Vol. 9, Iss. 2, pp. 208-245
Open Access | Times Cited: 1704
Blood-Brain Barrier: From Physiology to Disease and Back
Melanie D. Sweeney, Zhen Zhao, Axel Montagne, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 21-78
Open Access | Times Cited: 1648
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois, Harald Hampel, Howard Feldman, et al.
Alzheimer s & Dementia (2016) Vol. 12, Iss. 3, pp. 292-323
Open Access | Times Cited: 1633
Microglia in Alzheimer’s disease
David V. Hansen, Jesse E. Hanson, Morgan Sheng
The Journal of Cell Biology (2017) Vol. 217, Iss. 2, pp. 459-472
Open Access | Times Cited: 1555
2015 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2015) Vol. 11, Iss. 3, pp. 332-384
Closed Access | Times Cited: 1545
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Bengt Winblad, Philippe Amouyel, Sandrine Andrieu, et al.
The Lancet Neurology (2016) Vol. 15, Iss. 5, pp. 455-532
Open Access | Times Cited: 1490
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Mathias Jucker, Lary C. Walker
Nature (2013) Vol. 501, Iss. 7465, pp. 45-51
Open Access | Times Cited: 1478
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Eric Tönnies, Eugenia Trushina
Journal of Alzheimer s Disease (2017) Vol. 57, Iss. 4, pp. 1105-1121
Open Access | Times Cited: 1446
Page 1 - Next Page

Scroll to top